Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 5/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | HTR3A | P46098 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21186203 | 0.81 | ALDH1A1 (0.37) | TSHRALDH1A1RAB9AGAA | |
| SCHEMBL1397175 | 0.71 | MAOB (0.34) | CHRNA7 | |
| SCHEMBL1130234 | 0.68 | HRH1 (0.31) | HRH1CHRNA7HTR3A | |
| SCHEMBL1130836 | 0.68 | HRH1 (0.31) | HRH1 | |
| SCHEMBL20270422 | 0.66 | LTA4H (0.43) | SLC6A4SLC6A3SLC6A2HRH1HTR1A | |
| SCHEMBL3223091 | 0.66 | CHRNA7 (0.38) | SLC6A3SLC6A2CHRNA7HTR3ATSHR | |
| SCHEMBL6053771 | 0.66 | GRIN2D (0.50) | — | |
| SCHEMBL24177909 | 0.65 | SLC6A2 (0.38) | SLC6A4SLC6A3SLC6A2HRH1DDB1 | |
| SCHEMBL13875064 | 0.64 | CA4 (0.39) | SLC6A4SLC6A3SLC6A2HRH1HTR1A | |
| SCHEMBL27520666 | 0.63 | FAAH (0.44) | ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3971804-A | ACARICIDES, FUNGICIDES, INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | claimed |
| US-20090012324-A1 | Process for Production of Carboxylic Acid Ester or Ether Compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2009-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012324-A1 | Process for Production of Carboxylic Acid Ester or Ether Compound | TECR, CA14, ACSL4 | SLC6A4 2510/4885SLC6A3 3183/4885SLC6A2 3301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.